Multimodality Imaging in Valvular Heart Disease: Echocardiography or MRI

Monday, April 4, 8:00-9:30 AM

Valve disease is on the rise, especially as people live longer. Echocardiography has been the staple imaging modality for the valves; however, MRI has proved its worth. The problem is that echo is so pervasive, while MRI is still considered a niche modality. Perhaps many cardiologists and referring physicians are unaware of the strength of MRI to be effective in particular clinical scenarios. If that is the case, this session should provide ample opportunity to learn how each imaging technique can be used for valvular disease. This type of pro/con format always promises to be informative.

Speaker Information

  • Stephen H. Little, MD, Methodist DeBakey Heart and Vascular Center, Houston -- Echocardiography is Best for Assessing Mitral Regurgitation Severity
  • Robert W. Biederman, MD, Allegheny General Hospital, Pittsburgh, Pa. -- MRI Is Best for Assessing Mitral Regurgitation Severity
  • Vera H. Rigolin, MD, Northwestern Memorial Hospital, Chicago -- Echocardiography Is Best for Assessment of Aortic Regurgitation Severity
  • Eli V. Gelfand, MD, Beth Israel Deaconess Medical Center, Boston -- MRI Is Best for Assessment of Aortic Regurgitation Severity
  • Nelson B. Schiller, MD, University of California, San Francisco -- Echocardiography Is Best for Assessment of Aortic Stenosis
  • Carlos E. Rochitte, MD, University of São Paulo Medical School, Brazil -- MRI Is Best for Assessment of Aortic Stenosis Severity

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.